These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21971231)

  • 21. Bibliography. Current world literature. Transfusion medicine.
    Curr Opin Hematol; 2001 Nov; 8(6):B140-51. PubMed ID: 11710320
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of depletion of 2, 3-diphosphoglycerate by transfusion of ACD-stored blood on the buffer capacity of whole blood and erythrocytes (author's transl)].
    Kato A; Kato Y; Nampo T; Aruga K
    Masui; 1978 Aug; 27(8):794-800. PubMed ID: 691243
    [No Abstract]   [Full Text] [Related]  

  • 23. A program to limit donor exposures to neonates undergoing extracorporeal membrane oxygenation.
    Rosenberg EM; Chambers LA; Gunter JM; Good JA
    Pediatrics; 1994 Sep; 94(3):341-6. PubMed ID: 8065860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red blood cells frozen thawed and washed in the original collection bag.
    Reverberi R; Moretti M; Squarzoni G; Menini C
    Riv Emoter Immunoematol; 1980; 27(3-4):211-7. PubMed ID: 7339850
    [No Abstract]   [Full Text] [Related]  

  • 25. [Problems of massive transfusion].
    Rainer H
    Z Krankenpfl; 1974 Nov; 67(11):408-11. PubMed ID: 4499146
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of the vital capacity of erythrocytes of cadaver blood using the isotope chromium Cr 51].
    Suvorova IA; Pafomov GA; Tal'skaia IN; Oldurova SV
    Probl Gematol Pereliv Krovi; 1970 Apr; 15(4):26-8. PubMed ID: 5453824
    [No Abstract]   [Full Text] [Related]  

  • 27. [GEK-NEU: triply washed erythrocytes from O Rh-negative and CMV-seronegative donors withdrawn less than 4 days before transfusion into newborn infants at risk].
    Diekamp U; Miceli C; Gylys L; Caccese M
    Beitr Infusionther Klin Ernahr; 1987; 18():133-9. PubMed ID: 2830875
    [No Abstract]   [Full Text] [Related]  

  • 28. [Improved method of obtaining a leukocyte suspension for component blood transfusion therapy].
    Volkova SD; Kuz'min VA; Mel'nikova VN; Platonova GG; Shulutko LS
    Probl Gematol Pereliv Krovi; 1981 Dec; 26(12):43-6. PubMed ID: 7329958
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood component therapy: differential indication for erythrocyte transfusion].
    Bergmann H
    Infusionsther Klin Ernahr; 1980 Aug; 7(4):184-9. PubMed ID: 7191413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New trends in blood component therapy.
    Högman CF
    Haematologia (Budap); 1983; 16(1-4):23-38. PubMed ID: 6383964
    [No Abstract]   [Full Text] [Related]  

  • 31. [Practical problems inherent in the use in transfusion of frozen erythrocyte preservation and preparation methods].
    Terzi I
    Ann Med Nav (Roma); 1970; 75(2):105-10. PubMed ID: 5485049
    [No Abstract]   [Full Text] [Related]  

  • 32. [Limitations of mass transfusion].
    Busch H
    Infusionsther Klin Ernahr; 1978 Oct; 5(5):294-6. PubMed ID: 568601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rejuvenation of stored human red blood cells reverses the renal microvascular oxygenation deficit in an isovolemic transfusion model in rats.
    Raat NJ; Hilarius PM; Johannes T; de Korte D; Ince C; Verhoeven AJ
    Transfusion; 2009 Mar; 49(3):427-4. PubMed ID: 19040497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Targeted hemotherapy (blood transfusion using the correct amount)].
    Reissigl H
    Z Kinderchir; 1983 Jun; 38(3):130-8. PubMed ID: 6637113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Functional capacity of erythrocytes in preserved blood].
    Seidl S
    Dtsch Med Wochenschr; 1972 May; 97(20):817. PubMed ID: 5021637
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evolution of neonatal transfusion practices: current recommendations].
    Plaisant F
    Transfus Clin Biol; 2011 Apr; 18(2):262-8. PubMed ID: 21440478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transfusion of blood and products derived from blood].
    Wautier JL
    Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693
    [No Abstract]   [Full Text] [Related]  

  • 38. [Targetted hemotherapy with special reference to the cellular components].
    Dörner R
    Dtsch Med Wochenschr; 1990 Jul; 115(27):1066-72. PubMed ID: 2194776
    [No Abstract]   [Full Text] [Related]  

  • 39. Proteomics and transfusion medicine: future perspectives.
    Queloz PA; Thadikkaran L; Crettaz D; Rossier JS; Barelli S; Tissot JD
    Proteomics; 2006 Oct; 6(20):5605-14. PubMed ID: 16972297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Blood transfusion. 1. Whole blood transfusion].
    Wehrlin N
    Rev Infirm; 1982 Apr; 32(7):35-43. PubMed ID: 6919189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.